Multiple Doses of Anti-NOGO A in Relapsing Forms of Multiple Sclerosis

Inclusion Criteria

• •Diagnosed with a relapsing form of MS .
• •Using one of the following ongoing MS treatment strategies, defined as
• •1. Currently receiving Beta-interferon/Copaxone for treatment of MS and have been receiving the current course of therapy for 3 or more months prior to screening, OR
• •2. Not currently receiving disease modifying therapies for treatment of MS, and has not received such therapies for at least 3 months prior to screening.
• •Demonstrated clinical activity in 2 years prior to screening, whilst receiving current/previous treatment regimen or prior to any treatment regimen
• •Expanded Disability Status Scale (EDSS) score ≤6.0 at either the screening or baseline visit.
• •Male or female between 18 and 60 years of age inclusive, at the time of signing the informed consent.
• •Body weight equal to or greater than: 50 kilogrammes